A pilot study of oxidative pathways in MS fatigue: randomized trial of N-acetyl cysteine.

Ann Clin Transl Neurol · 2021 · PMC8045913 · PMID 33675156

Europe PMC DOI

hedged sentence

0.1800

closest p · 3.6× alpha

0.1800

boldest claim

The sentences

did not reach statistical significancep = 0.18not close (p > 0.1)

From week 4 to 6, after being off the study drug for 2 weeks, fatigue worsened in both groups, but to a greater extent in the placebo (14‐point worsening) compared to NAC (2‐point worsening) group, although this did not reach statistical significance ( p = 0.18).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.